Proteros biostructures Overview
- Year Founded
-
1998
- Status
-
Private
- Employees
-
163
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
5
- Investments
-
1
Proteros biostructures General Information
Description
Operator of a biotechnology and drug discovery company intended to unlock even the most technically challenging drug targets. The company offers research services for early drug development in the areas of pharmaceuticals, biochemistry and plant protection, thereby enabling clients to reach the right results and accelerate their overall research timelines for their clients, opening the door to lead optimization and clinical programs.
Contact Information
Website
www.proteros.comCorporate Office
- Bunsenstraße 7a
- 82152 Martinsried
- Germany
Corporate Office
- Bunsenstraße 7a
- 82152 Martinsried
- Germany
Proteros biostructures Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Proteros biostructures Comparisons
Industry
Financing
Details
Proteros biostructures Competitors (4)
One of Proteros biostructures’s 4 competitors is Nanion Technologies, a Accelerator/Incubator Backed company based in Munich, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Nanion Technologies | Accelerator/Incubator Backed | Munich, Germany | ||||
| Sapidyne Instruments | Corporation | Waukesha, WI | ||||
| NanoTemper Technologies | Corporation | Munich, Germany | ||||
| Carterra | Venture Capital-Backed | Salt Lake City, UT |
Proteros biostructures Patents
Proteros biostructures Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4686943-A1 | Method of identifying one or more compounds capable of binding to a biological target | Pending | 31-Jul-2024 | ||
| WO-2026027654-A1 | Method of identifying one or more compounds capable of binding to a biological target | Pending | 31-Jul-2024 | ||
| EP-3094725-A1 | Nucleosome substrate assays | Active | 13-Jan-2014 | ||
| EP-3094725-B1 | Nucleosome substrate assays | Active | 13-Jan-2014 | ||
| EP-3495484-A1 | Nucleosome substrate assays | Inactive | 13-Jan-2014 | G01N33/6875 |
Proteros biostructures Signals
Proteros biostructures Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Proteros biostructures Investments (1)
Proteros biostructures’s most recent deal was a Early Stage VC with Rodin Therapeutics for . The deal was made on 29-May-2014.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Rodin Therapeutics | 29-May-2014 | Early Stage VC | Drug Discovery |
Proteros biostructures Exits (1)
Proteros biostructures’s most recent exit was on 29-May-2014 from Rodin Therapeutics. The exit was categorized as with 4 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Rodin Therapeutics | 29-May-2014 | Completed |
|
Proteros biostructures FAQs
-
When was Proteros biostructures founded?
Proteros biostructures was founded in 1998.
-
Where is Proteros biostructures headquartered?
Proteros biostructures is headquartered in Martinsried, Germany.
-
What is the size of Proteros biostructures?
Proteros biostructures has 163 total employees.
-
What industry is Proteros biostructures in?
Proteros biostructures’s primary industry is Drug Discovery.
-
Is Proteros biostructures a private or public company?
Proteros biostructures is a Private company.
-
What is Proteros biostructures’s current revenue?
The current revenue for Proteros biostructures is .
-
How much funding has Proteros biostructures raised over time?
Proteros biostructures has raised $11.9M.
-
Who are Proteros biostructures’s investors?
Inflexion Private Equity Partners has invested in Proteros biostructures.
-
Who are Proteros biostructures’s competitors?
Nanion Technologies, Sapidyne Instruments, NanoTemper Technologies, and Carterra are competitors of Proteros biostructures.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process